Life360 (LIF) director reports 105,456 shares beneficially owned

Q: What insider transaction did Life360 (LIF) disclose?

A director exercised 7,930 stock options at $11.18 and sold 7,930 shares at $103.20 on October 13, 2025 .

Q: Was the Life360 (LIF) trade under a Rule 10b5-1 plan?

Yes. The filing states the trades were pursuant to a Rule 10b5-1 plan adopted on March 14, 2025 .

Q: How many Life360 (LIF) shares does the insider hold after the trade?

The reporting person beneficially owned 105,456 shares after the reported transactions.

Q: Do the reported holdings include RSUs for Life360 (LIF)?

Yes. The holdings include 2,036 RSUs , each representing the right to receive one share upon vesting.

Q: What is the expiration date of the exercised Life360 (LIF) option?

The option is shown with an expiration date of April 12, 2028 and an exercise price of $11.18 .

Filing Impact

(High)

Filing Sentiment

(Negative)

Form Type

Rhea-AI Filing Summary

Life360 (LIF) reported an insider transaction: a company director filed a Form 4 for activity on October 13, 2025. The reporting person exercised 7,930 stock options at an exercise price of $11.18 per share and, on the same date, sold 7,930 shares at a price of $103.20 per share. The transactions were executed under a Rule 10b5-1 trading plan adopted on March 14, 2025.

Following these transactions, the reporting person beneficially owned 105,456 shares of common stock. This figure includes 2,036 restricted stock units, each representing a right to receive one share upon vesting. The exercised option relates to a grant with a vesting schedule that began April 12, 2024 and monthly thereafter, and carries an expiration date of April 12, 2028.

Insights

Routine Form 4: planned option exercise and sale under 10b5-1.

The filing shows a director exercised 7,930 options at $11.18 and sold 7,930 shares at $103.20 on October 13, 2025. The activity was conducted under a Rule 10b5-1 plan adopted on March 14, 2025, indicating a pre-arranged, criteria-based trading program.

Post-transaction holdings are 105,456 common shares, which include 2,036 RSUs. The option grant vests over time and expires on April 12, 2028. As a routine disclosure of insider activity, this is generally neutral for the investment thesis.

Insider Trade Summary

Net Seller: 7,930 shares ($818,376)

Net Sell 3 txns

Insider Prober Charles J.

Role Director

Sold 7,930 shs ($818K)

Type	Security	Shares	Price	Value
Exercise	Stock Option (right to buy)	7,930	$0.00	--
Exercise	Common stock	7,930	$11.18	$89K
Sale	Common stock	7,930	$103.20	$818K

Holdings After Transaction: Stock Option (right to buy) — 103,090 shares (Direct); Common stock — 113,386 shares (Direct)

Footnotes (1)

The transaction reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 14, 2025. The Rule 10b5-1 trading plan is a written, pre-established trading plan that provides for the automatic sale of Company stock pursuant to predetermined criteria. The Reporting Person adopted the plan at a time when they were not aware of any material nonpublic information about the Company. Includes 2,036 restricted stock units previously granted, each of which represents a contingent right to receive one share of the Issuer's common stock upon vesting. The stock option vests and becomes exercisable as to 1/2 of the total number of shares on April 12, 2024 and thereafter vests and becomes exercisable as to 1/48th of the total number of shares in equal monthly installments, until such time as the option is 100% vested, subject to the continuing service of the Reporting Person on each vesting date.

Form 4 Insider Transactions: What Each Field Means →

10/15/2025 - 06:48 PM

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Prober Charles J.

(Last)

(First)

(Middle)

C/O LIFE360, INC.

1900 SOUTH NORFOLK STREET, SUITE 310

(Street)

SAN MATEO

94403

(City)

(State)

(Zip)

2. Issuer Name and Ticker or Trading Symbol
Life360, Inc. [ LIF ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director	10% Owner
	Officer (give title below)	Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
10/13/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Common stock	10/13/2025		M⁽¹⁾		7,930	A	$11.18	113,386⁽²⁾	D
Common stock	10/13/2025		S⁽¹⁾		7,930	D	$103.2	105,456⁽²⁾	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
Stock Option (right to buy)	$11.18	10/13/2025		M⁽¹⁾			7,930	⁽³⁾	04/12/2028	Common stock	7,930	$0	103,090	D

Explanation of Responses:

1. The transaction reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 14, 2025. The Rule 10b5-1 trading plan is a written, pre-established trading plan that provides for the automatic sale of Company stock pursuant to predetermined criteria. The Reporting Person adopted the plan at a time when they were not aware of any material nonpublic information about the Company.

2. Includes 2,036 restricted stock units previously granted, each of which represents a contingent right to receive one share of the Issuer's common stock upon vesting.

3. The stock option vests and becomes exercisable as to 1/2 of the total number of shares on April 12, 2024 and thereafter vests and becomes exercisable as to 1/48th of the total number of shares in equal monthly installments, until such time as the option is 100% vested, subject to the continuing service of the Reporting Person on each vesting date.

Remarks:

	/s/ Jay Sood, Attorney-in-Fact	10/15/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

Source: View Original Filing on SEC EDGAR

FAQ

What insider transaction did Life360 (LIF) disclose?

A director exercised 7,930 stock options at $11.18 and sold 7,930 shares at $103.20 on October 13, 2025.

Was the Life360 (LIF) trade under a Rule 10b5-1 plan?

Yes. The filing states the trades were pursuant to a Rule 10b5-1 plan adopted on March 14, 2025.

How many Life360 (LIF) shares does the insider hold after the trade?

The reporting person beneficially owned 105,456 shares after the reported transactions.

Do the reported holdings include RSUs for Life360 (LIF)?

Yes. The holdings include 2,036 RSUs, each representing the right to receive one share upon vesting.

What is the expiration date of the exercised Life360 (LIF) option?

The option is shown with an expiration date of April 12, 2028 and an exercise price of $11.18.